Background The prevalence of aluminum (Al) intoxication has declined over the past 3 decades. However, different groups still report on the diagnosis of Al in bone. Prolonged and low-intensity exposures to Al may not be captured by serum Al measurements, preventing its proper diagnosis. We hypothesize that bone Al accumulation may be related to bone and cardiovascular events in the current Era. Aims To detect the diagnosis of bone Al accumulation; to explore bone and cardiovascular consequences of Al accumulation. Methods This is a sub-analysis of The Brazilian Registry of Bone Biopsy, a prospective, multicentre cohort, with a mean follow-up of 3.4 years, including patients with CKD undergoing bone biopsy; bone fracture and major cardiovascular events (MACE) were adjudicated; Al accumulation was identified by solochrome-azurine staining; history of previous Al accumulation was registered based on information provided by the nephrologist who performed the bone biopsy; bone histomorphometry parameters, clinical data, and general biochemistry were registered. Results 275 individuals were considered; 96 (35%) patients have diagnosed with bone Al accumulation and were younger [50 (41–56) vs. 55 (43–61) years; p = 0.026], had lower body mass index [23.5 (21.6–25.5) vs. 24.3 (22.1–27.8) kg/m2; p = 0.017], higher dialysis vintage [108 (48–183) vs. 71 (28–132) months; p = 0.002], presented pruritus [23 (24%) vs. 20 (11%); p = 0.005], tendon rupture [7 (7%) vs. 3 (2%); p = 0.03) and bone pain [2 (0–3) vs. 0 (0–3) units; p = 0.02]. Logistic regression reveals that prior bone Al accumulation [OR: 4.517 (CI: 1.176–17.353); p = 0.03] and dialysis vintage [OR: 1.003 (CI: 1.000–1.007); p = 0.046] as independent determinants of bone Al accumulation; minor perturbations in dynamic bone parameters and no differences in bone fractures rate were noted; MACE was more prevalent in patients with bone Al accumulation [21 (34%) vs. 23 (18%) events; p = 0.016]. Cox regression shows the actual/prior diagnosis of bone Al accumulation and diabetes mellitus as independent predictors for MACE: [HR = 3.129 (CI: 1.439–6.804; p = 0.004) and HR = 2.785 (CI: 1.120–6.928; p = 0.028]. Conclusions An elevated proportion of patients have bone Al accumulation, associated with a greater prevalence of bone pain, tendon rupture, and pruritus; bone Al accumulation was associated with minor perturbations in renal osteodystrophy; actual/prior diagnosis of bone Al accumulation and diabetes mellitus were independent predictors for MACE.
Embora utilizada há cerca de 50 anos, a iodoterapia é uma terapêutica pouco divulgada, sendo capaz de tratar desde patologias benignas até neoplásicas. Este estudo tem como objetivo identificar e analisar a produção de conhecimentos relacionados ao portador de câncer de tireoide submetido à radioiodoterapia. Realizou-se revisão integrativa nas bases de dados SciELO e Biblioteca Virtual em Saúde. Dentre os artigos publicados, 10 foram selecionados e analisados a partir do agrupamento em 4 áreas temáticas. Verificou-se uma carência de estudos relacionados a assistência de enfermagem, visto que os trabalhos vêm discutindo, principalmente, questões referentes à terapêutica da iodoterapia. Conclui-se que o estudo apresentou resultados com uma relevância significativa para a prática assistencial, entretanto ressalta-se a necessidade de valorização da produção científica pelo profissional enfermeiro.Descritores: Neoplasia da Glândula Tireoide, Iodo, Enfermagem Oncológica. Contributions to assistance to thyroid cancer patient submitted to radioiodine therapyAbstract: Although used about fifty years, iodine therapy is a little disclosed, being able to treat even benign and malignant pathologies. This study aims to identify and analyze the production of knowledge related to the thyroid cancer patient submitted to radioiodine therapy. An integrative review was done in SCIELO and Biblioteca Virtual em Saúde databases. Among the published papers, ten were selected and analyzed from grouping in four thematic areas. A lack of studies related to nursing care was verified, since the papers mainly discussing questions referred to iodine therapy. It concludes that this study presents results with a significant relevance to care practice. However, it was noticed the needing for improvement of scientific production by the nurse professional.Descriptors: Thyroid Neoplasm, Iodine, Oncology Nurse. Contribuciones para la asistencia al enfermo con cancer de tiroide sometido a radioyodoterapiaResumen: Aún que sea utilizada a 50 años, la yodoterapia es una terapia poco divulgada, siendo capaz de tratar patologíasbenignas hasta malignas. Este estudio tiene como objetivo identificar y analizar la producción de conocimientos relacionados al portador de cancer de tiroides sometido a radioyodoterapia. Se realizó una revisión integrativa em las bases de datos Scielo y Biblioteca Virtual em Saúde. Entre todos los artículos publicados, 10 fueron seleccionados y analizados, a partir del agrupamiento em 4 áreas temáticas. Se verificó una carencia de estudios relacionados a a asistencia de enfermaría, ya que los trabajos vienen discutiendo, principalmente, cuestiones relacionadas a la yodoterapia. Se concluye que el estudio presentó resultados com una relevancia significativa para la práctica asistencial, sin embargo se resaltar la necesidad de valorizaciónde la producción científica por el profesional de enfermero.Descriptores: Neoplasia de la Glándula Tiroide, Yodo, Enfermería Oncológica.
Advanced glycation end products (AGEs) accumulation may be involved in the progression of CKD‐bone disorders. We sought to determine the relationship between AGEs measured in the blood, skin, and bone with histomorphometry parameters, bone protein, gene expression, and serum biomarkers of bone metabolism in patients with CKD stages 3 to 5D patients. Serum levels of AGEs were estimated by pentosidine, glycated hemoglobin (A1c), and N‐carboxymethyl lysine (CML). The accumulation of AGEs in the skin was estimated from skin autofluorescence (SAF). Bone AGEs accumulation and multiligand receptor for AGEs (RAGEs) expression were evaluated by immunohistochemistry; bone samples were used to evaluate protein and gene expression and histomorphometric analysis. Data are from 86 patients (age: 51 ± 13 years; 60 [70%] on dialysis). Median serum levels of pentosidine, CML, A1c, and SAF were 71.6 pmol/mL, 15.2 ng/mL, 5.4%, and 3.05 arbitrary units, respectively. AGEs covered 3.92% of trabecular bone and 5.42% of the cortical bone surface, whereas RAGEs were expressed in 0.7% and 0.83% of trabecular and cortical bone surfaces, respectively. AGEs accumulation in bone was inversely related to serum receptor activator of NF‐κB ligand/parathyroid hormone (PTH) ratio (R = −0.25; p = 0.03), and RAGE expression was negatively related to serum tartrate‐resistant acid phosphatase‐5b/PTH (R = −0.31; p = 0.01). Patients with higher AGEs accumulation presented decreased bone protein expression (sclerostin [1.96 (0.11–40.3) vs. 89.3 (2.88–401) ng/mg; p = 0.004]; Dickkopf‐related protein 1 [0.064 (0.03–0.46) vs. 1.36 (0.39–5.87) ng/mg; p = 0.0001]; FGF‐23 [1.07 (0.4–32.6) vs. 44.1 (6–162) ng/mg; p = 0.01]; and osteoprotegerin [0.16 (0.08–2.4) vs. 6.5 (1.1–23.7) ng/mg; p = 0.001]), upregulation of the p53 gene, and downregulation of Dickkopf‐1 gene expression. Patients with high serum A1c levels presented greater cortical porosity and Mlt and reduced osteoblast surface/bone surface, eroded surface/bone surface, osteoclast surface/bone surface, mineral apposition rate, and adjusted area. Cortical thickness was negatively correlated with serum A1c (R = −0.28; p = 0.02) and pentosidine levels (R = −0.27; p = 0.02). AGEs accumulation in the bone of CKD patients was related to decreased bone protein expression, gene expression changes, and increased skeletal resistance to PTH; A1c and pentosidine levels were related to decreased cortical thickness; and A1c levels were related to increased cortical porosity and Mlt. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.